Published on November 7, 2018
Updated on March 7, 2019
MEDIA CONTACT: Hayley Cooke
Alexandria, Va. — On November 5 and 6, the Prevent Cancer Foundation® brought together experts and leaders in science, policy and practice at the Quantitative Imaging Workshop XV: Lung Cancer, COPD and Cardiovascular Disease (QIW). The Workshop is a high-impact, multi-disciplinary forum for the advancement of quantitative CT imaging biomarkers for management of early thoracic disease.
The Foundation has convened this annual workshop since 2003, with a focus on high-resolution CT imaging data for lung cancer, COPD and cardiovascular disease. The Workshop provides a forum to exchange ideas on quantitative CT imaging for early disease management, as well as on policy and advocacy for responsible lung cancer, COPD and cardiovascular screening. This event emphasizes quality and consistency in screening.
Each year, this unique forum brings together leaders in lung cancer, COPD and cardiovascular disease early detection and treatment of early-stage disease, including oncologists, radiologists, photonics experts, federal policymakers and regulators, pharmaceutical professionals and patient advocates.
Sharon Y. Eubanks, known for her work as lead council in the federal tobacco litigation, United States v. Philip Morris USA, et al., was honored at the Workshop with the James L. Mulshine, M.D. Leadership Award.